Biomarkers of inflammation and oxidative stress in smokers and severe chronic obstructive pulmonary disease patients

---

Original Article

Author Details : Mohammed Asimuddin*, Gutta Vijaylakshmi, Mohd Soheb Ansari, Kaiser Jamil

Volume : 5, Issue : 3, Year : 2020

Article Page : 173-180

https://doi.org/10.18231/j.ijirm.2020.053

Suggest article by email

Get Permission

---

Abstract

Introduction: Identification of biomarkers for the novel therapeutics targets of Chronic obstructive pulmonary disease (COPD) is an important area of current research. In this study, the level of inflammatory cytokines was investigated and correlated these levels with erythrocytic antioxidant activities in COPD patients with smokers and without smokers and parameters of severity.
Material and Methods: Plasma levels of Interleukin (IL)-6, IL-8 and IL-10 concentrations were assayed by means of Enzyme-linked Immunosorbent Assay (ELISA) and erythrocytic glutathione-stransferase (GST) and glutathione peroxidase (GPx) activities were estimated by spectrophotometric method.
Results: Both IL-6 and IL-8 plasma levels showed a statistically significantly higher in COPD patients as compared to healthy controls (p<0 xss=removed xss=removed xss=removed>0.05) and GPx activities (r= - 0.080, p>0.05). Similarly IL-8 was also
found negative association with GST (r= - 0.260, p>0.05) and GPx activities (r= - 0.268, p>0.05). Whereas, a significant positive association was observed between IL-10 and erythrocytic GST (r= 0.494, p <0 xss=removed> Conclusion: In conclusion, Plasma levels of inflammatory cytokines IL-6 and IL-8 are related with severity of COPD and IL-10 and oxidative stress markers GST and GPx are co-dependent and strongly interrelated processes and may be used as a potential marker for the evaluation of COPD.

Keywords: Erythrocyte, Plasma, Interleukin6 (IL6), IL8, IL10, GST, GPx.

How to cite : Asimuddin M, Vijaylakshmi G, Ansari M S, Jamil K, Biomarkers of inflammation and oxidative stress in smokers and severe chronic obstructive pulmonary disease patients. IP Indian J Immunol Respir Med 2020;5(3):173-180

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.